IMCR - Immunocore GAAP EPS of -$0.48 beats by $0.60 revenue of $29.56M beats by $21.4M May, 11 2022 07:41 AM Immunocore Holdings plc Immunocore press release (NASDAQ:IMCR): Q1 GAAP EPS of -$0.48 beats by $0.60. Revenue of $29.56M (+171% Y/Y) beats by $21.4M. For further details see: Immunocore GAAP EPS of -$0.48 beats by $0.60, revenue of $29.56M beats by $21.4M